全文获取类型
收费全文 | 237篇 |
免费 | 1篇 |
专业分类
系统科学 | 1篇 |
理论与方法论 | 3篇 |
现状及发展 | 39篇 |
研究方法 | 33篇 |
综合类 | 159篇 |
自然研究 | 3篇 |
出版年
2021年 | 1篇 |
2016年 | 1篇 |
2015年 | 2篇 |
2014年 | 2篇 |
2013年 | 2篇 |
2012年 | 8篇 |
2011年 | 16篇 |
2010年 | 2篇 |
2008年 | 20篇 |
2007年 | 10篇 |
2006年 | 17篇 |
2005年 | 8篇 |
2004年 | 15篇 |
2003年 | 2篇 |
2002年 | 9篇 |
2001年 | 8篇 |
2000年 | 12篇 |
1999年 | 2篇 |
1995年 | 1篇 |
1993年 | 2篇 |
1992年 | 3篇 |
1990年 | 1篇 |
1989年 | 6篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 2篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1970年 | 8篇 |
1969年 | 3篇 |
1968年 | 7篇 |
1967年 | 4篇 |
1966年 | 7篇 |
1965年 | 3篇 |
1958年 | 2篇 |
1954年 | 1篇 |
排序方式: 共有238条查询结果,搜索用时 31 毫秒
81.
82.
A gene complex controlling segmentation in Drosophila. 总被引:198,自引:0,他引:198
The bithorax gene complex in Drosophila contains a minimum of eight genes that seem to code for substances controlling levels of thoracic and abdominal development. The state of repression of at least four of these genes is controlled by cis-regulatory elements and a separate locus (Polycomb) seems to code for a repressor of the complex. The wild-type and mutant segmentation patterns are consistent with an antero-posterior gradient in repressor concentration along the embryo and a proximo-distal gradient along the chromosome in the affinities for repressor of each gene's cis-regulatory element. 相似文献
83.
84.
85.
Metabolism of aflatoxin in sheep: excretion of the "milk toxin" 总被引:1,自引:0,他引:1
86.
87.
During gastrulation, a single epithelial cell layer, the ectoderm, generates two others: the mesoderm and the endoderm. In amniotes (birds and mammals), mesendoderm formation occurs through an axial midline structure, the primitive streak, the formation of which is preceded by massive 'polonaise' movements of ectoderm cells. The mechanisms controlling these processes are unknown. Here, using multi-photon time-lapse microscopy of chick (Gallus gallus) embryos, we reveal a medio-lateral cell intercalation confined to the ectodermal subdomain where the streak will later form. This intercalation event differs from the convergent extension movements of the mesoderm described in fish and amphibians (anamniotes): it occurs before gastrulation and within a tight columnar epithelium. Fibroblast growth factor from the extraembryonic endoderm (hypoblast, a cell layer unique to amniotes) directs the expression of Wnt planar-cell-polarity pathway components to the intercalation domain. Disruption of this Wnt pathway causes the mesendoderm to form peripherally, as in anamniotes. We propose that the amniote primitive streak evolved from the ancestral blastopore by acquisition of an additional medio-lateral intercalation event, preceding gastrulation and acting independently of mesendoderm formation to position the primitive streak at the midline. 相似文献
88.
Ethical quandaries aside, stem-cell science is attracting researchers worldwide. Ricki Lewis reports. 相似文献
89.
Chen Z Cheng K Walton Z Wang Y Ebi H Shimamura T Liu Y Tupper T Ouyang J Li J Gao P Woo MS Xu C Yanagita M Altabef A Wang S Lee C Nakada Y Peña CG Sun Y Franchetti Y Yao C Saur A Cameron MD Nishino M Hayes DN Wilkerson MD Roberts PJ Lee CB Bardeesy N Butaney M Chirieac LR Costa DB Jackman D Sharpless NE Castrillon DH Demetri GD Jänne PA Pandolfi PP Cantley LC Kung AL Engelman JA Wong KK 《Nature》2012,483(7391):613-617
Targeted therapies have demonstrated efficacy against specific subsets of molecularly defined cancers. Although most patients with lung cancer are stratified according to a single oncogenic driver, cancers harbouring identical activating genetic mutations show large variations in their responses to the same targeted therapy. The biology underlying this heterogeneity is not well understood, and the impact of co-existing genetic mutations, especially the loss of tumour suppressors, has not been fully explored. Here we use genetically engineered mouse models to conduct a 'co-clinical' trial that mirrors an ongoing human clinical trial in patients with KRAS-mutant lung cancers. This trial aims to determine if the MEK inhibitor selumetinib (AZD6244) increases the efficacy of docetaxel, a standard of care chemotherapy. Our studies demonstrate that concomitant loss of either p53 (also known as Tp53) or Lkb1 (also known as Stk11), two clinically relevant tumour suppressors, markedly impaired the response of Kras-mutant cancers to docetaxel monotherapy. We observed that the addition of selumetinib provided substantial benefit for mice with lung cancer caused by Kras and Kras and p53 mutations, but mice with Kras and Lkb1 mutations had primary resistance to this combination therapy. Pharmacodynamic studies, including positron-emission tomography (PET) and computed tomography (CT), identified biological markers in mice and patients that provide a rationale for the differential efficacy of these therapies in the different genotypes. These co-clinical results identify predictive genetic biomarkers that should be validated by interrogating samples from patients enrolled on the concurrent clinical trial. These studies also highlight the rationale for synchronous co-clinical trials, not only to anticipate the results of ongoing human clinical trials, but also to generate clinically relevant hypotheses that can inform the analysis and design of human studies. 相似文献
90.